Extreme metabolic alkalosis in a patient with recurrent vomiting due to cannabinoid hyperemesis syndrome
DOI:
https://doi.org/10.32818/reccmi.a6n3a2Keywords:
metabolic alkalosis, hyperemesis, hyponatremia, cannabis.Abstract
The Cannabinoid Hyperemesis Syndrome was described at the beginning of the xxi century. It can cause severe laboratory abnormalities, such as extreme metabolic alkalosis, associated with significant morbidity and mortality, requiring close monitoring and appropriate treatment to avoid serious complications. We report a 34-year-old male admitted to intensive care due to extreme metabolic alkalosis and severe diselectrolythemia in the context of Cannabinoid Hyperemesis Syndrome.
Downloads
Metrics
References
Kaplan LJ, Frangos S. Clinical review: Acid-base abnormalities in the intensive care unit - part II. Crit Care. 2005; 9(2): 198-203. doi: https://doi.org/10.1186/cc2912.
Tripathy S. Extreme metabolic alkalosis in intensive care. Indian J Crit Care Med. 2009; 13(4): 217-20. doi: https://doi.org/10.4103/0972-5229.60175.
Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004; 53(11): 1566-70. doi: https://doi.org/10.1136/gut.2003.036350.
Rimmer JM, Gennari FJ. Metabolic Alkalosis. J intensive Care Med. 1987; 2(3): 137-150. doi: https://doi.org/10.1177/088506668700200304.
Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev. 2011 Dec;4(4):241-9. doi: https://doi.org/10.2174/1874473711104040241.
Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, et al. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 2001; 121(4): 767-74. doi: https://doi.org/10.1053/gast.2001.28466.
Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007; 293(1): G137-45. doi: https://doi.org/10.1152/ajpgi.00565.2006.
McCallum RW, Soykan I, Sridhar KR, Ricci DA, Lange RC, Plankey MW. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther. 1999; 13(1): 77-80. doi: https://doi.org/10.1046/j.1365-2036.1999.00441.x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Enrique Chicote-Álvarez, Isabel Mainar-Gil, Elisa Monfort-Lázaro
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
